NCT00564954 - A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Dex-methylphenidate hydrochloride extended-release (Focalin XR)

20 mg capsule orally once a day for 7 days

DRUG

Placebo

orally once a day for 7 days

Trial Locations (5)

Novartis Investigative Site, Winter Park

Novartis Investigative Site, Little Rock

Novartis Investigative Site, Houston

Novartis Investigative Site, Lubbock

Novartis Investigative Site, Las Vegas